Table 3.
Indication | Product | A—Total Recommended Dosage a, Product Units | B—Amount of Neurotoxin Per Product Unit, pg | C—Total Amount of Active BoNT-A (ng) Injected at the Recommended Dose, C = A × B |
---|---|---|---|---|
AUL | Dysport® | 1000 | 5.38 | 5.38 |
Botox® | 400 | 9.04 | 3.62 | |
Xeomin® | 400 | 4.03 | 1.61 | |
ALL | Dysport® | 1500 | 5.38 | 8.07 |
Botox® | 400 | 9.04 | 3.62 | |
Xeomin® | 4.03 | |||
GL | Dysport® | 50 | 5.38 | 0.27 |
Botox® * | 20 | 9.04 | 0.18 | |
Xeomin® | 20 | 4.03 | 0.08 |